康泰医学收盘上涨2.14%，最新市净率3.02，总市值55.73亿元

Group 1 - The core viewpoint of the articles highlights the performance and recognition of Kangtai Medical, showcasing its growth in revenue and profit, as well as its recent awards for product design [1][2] Group 2 - As of May 12, Kangtai Medical's stock closed at 13.87 yuan, with a 2.14% increase, a price-to-book ratio of 3.02, and a total market capitalization of 5.573 billion yuan [1] - By the first quarter of 2025, three institutions held shares in Kangtai Medical, including two funds and one other entity, with a total holding of 3.3463 million shares valued at 0.046 billion yuan [1] - The company specializes in the research, production, and sales of medical diagnostic and monitoring equipment, covering various categories such as blood oxygen, electrocardiogram, ultrasound, monitoring, and blood pressure [1] - In April 2023, Kangtai Medical's Remoltar remote professional color Doppler ultrasound diagnostic system won the German IF Design Award and the Italian A Design Award [1] - In October 2023, the company's children's infrared thermometer won the silver award for design innovation at the 2023 Canton Fair, while its respiratory trainer and dynamic electrocardiogram monitor won bronze awards [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 112 million yuan, a year-on-year increase of 12.77%, and a net profit of 16.4358 million yuan, a year-on-year increase of 277.67%, with a gross profit margin of 58.15% [1] Group 3 - Kangtai Medical's PE (TTM) is -84.67, and its PE (static) is -71.54, with a price-to-book ratio of 3.02, compared to the industry average PE of 49.84 and a price-to-book ratio of 4.61 [2] - The industry median PE is 36.59, with a price-to-book ratio of 2.43, indicating that Kangtai Medical's valuation metrics are significantly lower than the industry averages [2]